SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community rallies around the meme-based token on Solana, celebrating its listing on Jupiter and the strength of its long-term holders. The community is actively spreading the word and engaging with the project's unique dad joke theme, asking 'What's UpDog?'

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI CRYPTO is trending as community members express bullish sentiment and highlight the project's strong community. Discussions mention potential for significant returns and comparisons to other meme coins. The community emphasizes unity and a shared goal of success, while also mentioning potential CoinMarketCap listing rumors.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around its cultural significance and roots in the crypto space. Active discussion points include references to its community, website, and links to DEX screeners. The coin aims to blend cryptocurrency with cannabis culture, fostering a community-driven approach.

Aventus Network

Aventus Network ($AVT) is trending as community members discuss its potential, citing its chart, real-world partnerships with Vodafone and Heathrow Airport, and Polkadot integration. The token's low market cap is also generating interest, with many watching for a volume increase that could lead to a breakout. Some users are optimistic about significant gains, while others mention its availability on Coinbase and Mexc.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as community members speculate about potential catalysts and buyout rumors, with some suggesting a potential acquisition by Eli Lilly. Discussions highlight the company's pipeline, particularly VK2735, and its potential in the consolidating metabolic disease market. The community is also focused on the upcoming maintenance dosage trial and earnings call, anticipating updates on expenses and Phase 3 enrollment.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community anticipates a potential breakout and discusses its role in real-world asset (RWA) applications. Conversations also focus on potential partnerships, revenue, and the possibility of token burns or buybacks. Some traders are watching for specific price levels to be reclaimed, expecting a squeeze.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as community members speculate about a potential manufacturing partnership or agreement with Tesla, especially with Tesla expected to make an announcement this week. The air taxi maker recently participated in an airshow and X users have also speculated that Tesla’s teaser could hint at its entry into the eVTOL space, potentially creating a $9 trillion market.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin ($BROKE) is gaining attention, with community members actively discussing its strong community and utility. The community is focused on earning more $BROKE through playing games on telegram, and they are collaborating with $UPDOG and $WAGMI communities. $BROKE is built on the Solana blockchain and is referred to as a meme coin by its community.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to a mix of factors, including a short squeeze narrative and increased attention on quantum computing stocks. Community discussions revolve around its high valuation, potential for further gains, and whether it's entering bubble territory, with some comparing it to other high-growth tech sectors. Andrew Left's short position and insider selling add another layer to the conversation.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals (CRML) is trending amid speculation around potential US government investment in its Greenland rare earths project. Community chatter revolves around the possible implications of government backing and potential benefits for related stocks, while some traders are eyeing a potential short squeeze. The stock is gaining increased attention as Western economies aim to diversify rare earth supply chains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Ensysce Biosciences, Inc. (ENSC) traded nearly 11% higher on Tuesday afternoon after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.ensysce.com/news/press-releases/detail/186/ensysce-biosciences-announces-positive-data-from-opioid">said</a> its PF614-MPAR pain relief medication demonstrated in a study that it can deliver strong relief for severe pain while protecting from the risk of excessive doses.The company completed the first part of its second clinical trial to evaluate PF614-MPAR for overdose protection. It confirmed that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed.CEO Bill Schmidt said that the clinical data demonstrates the ability of the company’s Multi-Pill Abuse Resistance (MPAR) platform as a vital tool to limit overdoses from prescription medications.Ensysce said that the maximum amount of oxycodone released from PF614-MPAR when three or more doses were taken at one time was reduced compared to that released following the consumption of the same amount of PF614 alone.The company said that the new data demonstrates overdose protection across the full dosage range of PF614-MPAR, which is planned for commercialization. It added that this analysis will be discussed with the U.S. Food and Drug Administration (FDA) in an upcoming meeting.The company will now continue to enroll for parts 2 and 3 of the clinical trial, which will allow it to perfect a final drug product for commercialization.On Stocktwits, retail sentiment around Ensysce Biosciences jumped nine points in the ‘extremely bullish’ territory while message volume remained ‘extremely high.’<figure class="image"><img style="aspect-ratio:1300/298;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_15_at_1_11_30_PM_png_9a122ca00d.webp" alt="ENSC's Sentiment Meter and Message Volume as of 1:30 p.m. ET on April 14, 2025 | Source: Stocktwits" width="1300" height="298"><figcaption>ENSC's Sentiment Meter and Message Volume as of 1:30 p.m. ET on April 14, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expressed optimism about the shares rallying to $6 from their current $2 levels.<stembedurl>https://stocktwits.com/LowFloatSniper/message/611712896</stembedurl><a href="https://stocktwits.com/symbol/ENSC">ENSC stock</a> is down nearly 73% year-to-date and about 78% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/barclays-downgrades-us-auto-sector-owing-to-trump-tariffs/chQRkPFRbOT">Barclays Downgrades US Auto Sector Owing To Trump’s Tariffs: Retail Sentiment Around GM Takes A Plunge</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Ensysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s Thrilled

The company stated that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed.

Equity

Ensysce Biosciences (ENSC) Stock Is Down 30% Today: What's Going On?

Ensysce Biosciences shares are trading lower by 30% during Thursday's session. The company announced a $5 million registered direct offering and concurrent private placement.
read more...

Ensysce Biosciences, Inc. (NASDAQ:ENSC) Sees Significant Decrease in Short Interest

Ensysce Biosciences, Inc. (NASDAQ:ENSC - Get Free Report) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 56,500...

Q4 2023 Ensysce Biosciences Inc Earnings Call Transcript

Ensysce Biosciences reports Q4 EPS ($1.13) vs. ($18.30) last year

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results

Corporate Update Call to be Held Thursday, March 21, 2024 at 11:00am ET to Discuss Recent FDA Breakthrough Therapy Designation and Phase 3 Clinical PlansSAN DIEGO, CA / ACCESSWIRE / March 15, 2024...

Ensysce Biosciences receives positive Nasdaq listing determination

Ensysce Biosciences Receives Positive Nasdaq Listing Determination

SAN DIEGO, CA / ACCESSWIRE / February 27, 2024 / Ensysce Biosciences, Inc. (the 'Company') (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug...

Ensysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose Protection

~ PF614-MPAR program receives FDA guidance ~SAN DIEGO, CA / ACCESSWIRE / February 21, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ('Ensysce' or the 'Company'), a clinical-stage company applying...

Ensysce Biosciences announces publication of clinical bioequivalence manuscript

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.

Ensysce Biosciences Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

ENSC
Ensysce Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ENSC News

ENSC Ensysce Biosciences Inc